Importantly, we first confirmed that treatment with anti-PD-1 mAb RMP1-14 alone had no impact on tumor growth and tumor endothelial cells in the MCAprog tumor model (Figures S9I–S9M).11 This evidence concerns the gene PDCD1 and neoplasm.